Evidence map›Paper›PMID 27814965›Full record

ReviewLancet (London, England)2017

The global burden of women's cancers: a grand challenge in global health.

Ophira Ginsburg, Freddie Bray, Michel P Coleman, Verna Vanderpuye, Alexandru Eniu, S Rani Kotha, Malabika Sarker, Tran Thanh Huong, Claudia Allemani, Allison Dvaladze and 11 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Lancet (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 540 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
540citing papers in PubMed, 12 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

540 citing papers in PubMed, 12 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. A systematic review of the cost-effectiveness of interventions to increase cervical cancer screening among underserved women in Europe.The European journal of health economics : HEPAC : health economics in prevention and care · 2024
    Pooled it
  10. Changes in the fecal microbiota of breast cancer patients based on 16S rRNA gene sequencing: a systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Pooled it
  11. Pooled it
  12. Pooled it
  13. Correlation of CTCAE and patient-reported breast radiation dermatitis symptom scores.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Trial
  14. Trial
  15. Menopausal hormone therapy and comprehensive postmenopausal care in gynecologic cancer survivors: A position paper from the FIGO Committee on Women at Menopausal Age.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational

480 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Ophira GinsburgWomen's College Research Institute, Faculty of Medicine, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; World Health Organization, Geneva, Switzerland. Electronic address: ophira.ginsburg@wchospital.ca.
Freddie BrayCancer Surveillance Section, International Agency for Research on Cancer, Lyon, France.
Michel P ColemanCancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Verna VanderpuyeNational Center for Radiotherapy, Korlebu Teaching Hospital, Accra, Ghana.
Alexandru EniuCancer Institute Ion Chiricuta, Cluj-Napoca, Romania.
S Rani KothaInstitute for Global Health Equity and Innovation, University of Toronto, Toronto, ON, Canada.
Malabika SarkerJames P Grant School of Public Health, BRAC University, Dhaka, Bangladesh.
Tran Thanh HuongHanoi Medical University and National Institute for Cancer Control, Hanoi, Vietnam.
Claudia AllemaniCancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Allison DvaladzeSeattle Cancer Care Alliance, Fred Hutchinson Cancer Research Centre, University of Washington, Seattle, WA, USA.
Julie GralowSeattle Cancer Care Alliance, Fred Hutchinson Cancer Research Centre, University of Washington, Seattle, WA, USA.
Karen YeatesQueen's University Faculty of Health Sciences, Office of Global Health, Queen's University, Kingston, ON, Canada.
Carolyn TaylorGlobal Focus on Cancer, Port Chester, NY, USA.
Nandini OommanIndependent Global Health Specialist, Washington, DC, USA.
Suneeta KrishnanResearch Triangle Institute Global India Pvt Ltd, New Delhi, India; St John's Research Institute, Bengarulu, India.
Richard SullivanInstitute of Cancer Policy, King's Health Partners Comprehensive Cancer Centre, London, UK; King's Centre for Global Health, King's Health Partners and King's College London, UK.
Dominista KombeOcean Road Cancer Centre, Dar es Salaam, Tanzania.
Magaly M BlasSchool of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru.
Groesbeck ParhamDepartment of Obstetrics and Gynecology University of North Carolina, Chapel Hill, NC, USA; University of Zambia, Lusaka, Zambia.
Natasha KassamiHealth Economics Group, School of Public Health, Imperial College London, London, UK.
Lesong ContehHealth Economics Group, School of Public Health, Imperial College London, London, UK.

Funding

Cancer Research UK 16148Cancer Research UK 18525Medical Research Council MR/K010174/1World Health Organization 001
6 · The paper itself

Abstract

Every year, more than 2 million women worldwide are diagnosed with breast or cervical cancer, yet where a woman lives, her socioeconomic status, and agency largely determines whether she will develop one of these cancers and will ultimately survive. In regions with scarce resources, fragile or fragmented health systems, cancer contributes to the cycle of poverty. Proven and cost-effective interventions are available for both these common cancers, yet for so many women access to these is beyond reach. These inequities highlight the urgent need in low-income and middle-income countries for sustainable investments in the entire continuum of cancer control, from prevention to palliative care, and in the development of high-quality population-based cancer registries. In this first paper of the Series on health, equity, and women's cancers, we describe the burden of breast and cervical cancer, with an emphasis on global and regional trends in incidence, mortality, and survival, and the consequences, especially in socioeconomically disadvantaged women in different settings.

Indexed as

Global HealthPovertyFemaleHumansIncidenceIncomeSocial ClassWomen's Health

Identifiers

PMID27814965
PMCPMC6191029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.